Eric Hongzheng Ma

Title: Eric Hongzheng Ma: Innovator in Monoclonal Antibodies

Introduction

Eric Hongzheng Ma is a notable inventor based in Zionsville, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has implications for agricultural biotechnology and plant research.

Latest Patents

Eric's latest patents include innovative methods and antibodies that are crucial for detecting specific toxins. One of his patents focuses on monoclonal antibodies specific for Cry1Ca and related detection methods. This patent describes murine monoclonal antibodies and methods useful for determining and quantitating the presence of Cry1Ca delta endotoxin. The claimed antibodies specifically bind the core toxin region, making them suitable for detecting the native full-length Cry1Ca toxin as well as the amino core toxin and N-terminal 29 residue truncated forms. Another significant patent involves monoclonal antibodies and detection methods for the phosphinothricin-N-acetyl-transferase enzyme. This invention is particularly useful for identifying and quantitating the presence of phosphinothricin-N-acetyl-transferase expressed in transgenic plants.

Career Highlights

Eric is currently employed at Dow Agrosciences LLC, where he continues to advance his research in biotechnology. His work has been instrumental in developing tools that enhance agricultural productivity and safety.

Collaborations

Throughout his career, Eric has collaborated with notable colleagues, including Guomin Shan and Todd P Glancy. These collaborations have fostered innovation and contributed to the success of his research projects.

Conclusion

Eric Hongzheng Ma is a distinguished inventor whose work in monoclonal antibodies has the potential to impact agricultural biotechnology significantly. His patents reflect a commitment to advancing scientific knowledge and practical applications in the field.